Malicioushypoglycemia Factitious hypoglycemia is a condition characterized by recurrent episodes of low blood sugar that are intentionally self-induced. Distinguishing factitious hypoglycemia from other causes of hypoglycemia, particularly insulinoma, is crucial for proper diagnosis and management. A key diagnostic tool in this differentiation is the measurement of C-peptide levels in conjunction with plasma insulin. Understanding the relationship between these biomarkers is essential for healthcare professionals and for individuals seeking to comprehend the complexities of this often challenging condition.
C-peptide is a byproduct of insulin production. When the pancreas releases insulin, it also releases an equimolar amount of C-peptide. Therefore, in cases of endogenous insulin production, such as with an insulinoma (a tumor of the pancreas that secretes insulin), both insulin and C-peptide levels will be elevated.
In contrast, factitious hypoglycemia, particularly when caused by the surreptitious injection of exogenous insulin, presents a different biochemical profile. When a person injects themselves with manufactured insulin, their body's own insulin production is suppressed.Factitious Hypoglycemia - Page 6 While plasma insulin levels will be high due to the injected insulin, the body's natural C-peptide production will be low or suppressed.Recognizing Factitious Hypoglycemia in the ... This discrepancy between high insulin and low C-peptide is a critical indicator of exogenous insulin use.
The diagnostic approach to recurrent hypoglycemia often involves a fasting test, where blood glucose, insulin, and C-peptide levels are measuredFactitious Hypoglycemia: Diagnosis by Measurement of ....
* Insulinoma: During a hypoglycemic episode in a patient with an insulinoma, laboratory tests typically reveal elevated levels of both plasma insulin and C-peptideFactitious hypoglycemia in insulin-treated diabetic patients. This indicates that the body is producing its own excess insulin.
* Factitious Hypoglycemia (Exogenous Insulin): In cases of factitious hypoglycemia induced by self-injection of insulin, the fasting test will show low blood glucose, high plasma insulin levels, and critically, suppressed or undetectable C-peptide levels. This pattern strongly suggests that the insulin is externally administered.
Another important diagnostic clue is the insulin-to-C-peptide ratio.Factitious hypoglycemia in insulin-treated diabetic patients In endogenous hyperinsulinism (like insulinoma), the ratio of insulin to C-peptide is typically normal or lowFactitious Hypoglycemia: Diagnosis by Measurement of .... However, in factitious hypoglycemia caused by exogenous insulin administration, this ratio is often significantly elevated.作者：JA Scarlett·1977·被引用次数：178—We made the diagnosis by measurements ofplasma insulin and C-peptide immunoreactivity(in seven patients), facilitated by the finding of circulating ... Some studies suggest that an insulin/C-peptide ratio greater than 1 may be useful in identifying hypoglycemia induced by factitious insulin injection. Similarly, an insulin to C-peptide ratio that is greater than 1.0 can be a significant indicator.
While exogenous insulin injection is a common cause of factitious hypoglycemia, other factors can mimic or contribute to the condition.The validity of C-peptide measurement in the diagnosis of ... Surreptitious ingestion of sulfonylureas, medications that stimulate the pancreas to release insulin, can also lead to hypoglycemia2002年5月8日—Normally, theC-peptidelevels increase when pancreatic secretion of insulin increases. Conversely, theC-peptidelevels decrease when .... In such cases, laboratory findings might show high insulin and C-peptide levels, but the C-peptide levels might be disproportionately high relative to the insulin, or other specific markers might be present. Therefore, a comprehensive evaluation, including a detailed patient history and potentially additional tests, is essential.
The C-peptide assay is a valuable tool in the diagnosis of fasting hypoglycemia, providing critical insights into the source of insulin.作者：PJ Guillausseau·1983·被引用次数：7—C-Peptide in Factitious Hypoglycemia from Sulfonylurea| Diabetes Care | American Diabetes Association. When faced with unexplained hypoglycemia, particularly in individuals with potential access to insulin or related medications, a careful assessment of C-peptide levels alongside insulin and glucose is paramount for accurate diagnosis and appropriate intervention.作者：PJ Guillausseau·1983·被引用次数：7—C-Peptide in Factitious Hypoglycemia from Sulfonylurea| Diabetes Care | American Diabetes Association. The distinction between endogenous and exogenous sources of insulin is vital for guiding treatment and addressing the underlying behavioral or psychiatric aspects of factitious disorders.
Join the newsletter to receive news, updates, new products and freebies in your inbox.